Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations

摘要: The incidence of malignant melanoma is increasing worldwide. In Spain, its faster than any other cancer type, with a 5-year survival rate about 85%. impact and characteristics in the Spanish population can be ascertained from national registry Academia Espanola de Dermatologia y Venereologia. This review presents consensus group recommendations for diagnosis, staging treatment Spain. Incidence mortality are discussed, as well evaluation various prevention strategies. Prognostic factors, such BRAF C-KIT mutations, which expected to become routine procedures over next few years, outlined, especially relation options. use recently approved targeted agents ipilimumab, cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) inhibitor, vemurafenib, metastatic disease also discussed.